Prestige Consumer Healthcare
PBH
$64.65
Share price
-0.51%
Change (1 day)
9.15%
Change (1 year)
Categories
P/S ratio for Prestige Consumer Healthcare (PBH)
P/S ratio as of May 2024 (TTM): 2.86
According to Prestige Consumer Healthcare's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.85964. At the end of 2023 the company had a P/S ratio of 2.68.
P/S ratio history for Prestige Consumer Healthcare from 2005 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 2.68 | -4.22% |
| 2022 | 2.80 | -2.68% |
| 2021 | 2.87 | 57.36% |
| 2020 | 1.83 | -14.52% |
| 2019 | 2.14 | 32.3% |
| 2018 | 1.61 | -29.68% |
| 2017 | 2.30 | -29.3% |
| 2016 | 3.25 | -5.72% |
| 2015 | 3.44 | 26.98% |
| 2014 | 2.71 | -10.89% |
| 2013 | 3.04 | 79.63% |
| 2012 | 1.69 | 20.28% |
| 2011 | 1.41 | -26.67% |
| 2010 | 1.92 | 44.81% |
| 2009 | 1.33 | -19.62% |
| 2008 | 1.65 | 43.07% |
| 2007 | 1.15 | -43.19% |
| 2006 | 2.03 | -4.25% |
| 2005 | 2.12 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 4.14 | 44.82% | 🇺🇸 USA |
 Procter & Gamble PG | 4.71 | 64.81% | 🇺🇸 USA |
 Novartis NVS | 4.20 | 46.77% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.80 | -2.03% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.55 | 59.06% | 🇺🇸 USA |
 Clorox CLX | 2.36 | -17.49% | 🇺🇸 USA |
 CVS Health CVS | 0.2001 | -93.00% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2.40 | -16.04% | 🇬🇧 UK |
 Rite Aid
RAD | 0.0016 | -99.95% | 🇺🇸 USA |
 Taro Pharmaceutical TARO | 2.60 | -9.20% | 🇮🇱 Israel |